Cargando…

Regulation of synaptic plasticity and cognition by SUMO in normal physiology and Alzheimer's disease

Learning and memory and the underlying cellular correlate, long-term synaptic plasticity, involve regulation by posttranslational modifications (PTMs). Here we demonstrate that conjugation with the small ubiquitin-like modifier (SUMO) is a novel PTM required for normal synaptic and cognitive functio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Linda, Dale, Elena, Staniszewski, Agnes, Zhang, Hong, Saeed, Faisal, Sakurai, Mikako, Fa', Mauro, Orozco, Ian, Michelassi, Francesco, Akpan, Nsikan, Lehrer, Helena, Arancio, Ottavio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4250909/ https://www.ncbi.nlm.nih.gov/pubmed/25448527 http://dx.doi.org/10.1038/srep07190

Ejemplares similares

Corrigendum: Regulation of synaptic plasticity and cognition by SUMO in normal physiology and Alzheimer’s disease
por: Lee, Linda, et al.
Publicado: (2015)

SUMO1 Affects Synaptic Function, Spine Density and Memory
por: Matsuzaki, Shinsuke, et al.
Publicado: (2015)

Caspase-9 mediates synaptic plasticity and memory deficits of Danish dementia knock-in mice: caspase-9 inhibition provides therapeutic protection
por: Tamayev, Robert, et al.
Publicado: (2012)

Dynamin 1 Is Required for Memory Formation
por: Fà, Mauro, et al.
Publicado: (2014)

Time-dependent reversal of synaptic plasticity induced by physiological concentrations of oligomeric Aβ42: an early index of Alzheimer’s disease
por: Koppensteiner, Peter, et al.
Publicado: (2016)

Role of phosphodiesterase 5 in synaptic plasticity and memory
por: Puzzo, Daniela, et al.
Publicado: (2008)

A role for tau in learning, memory and synaptic plasticity
por: Biundo, Fabrizio, et al.
Publicado: (2018)

PDE5 Exists in Human Neurons and is a Viable Therapeutic Target for Neurologic Disease
por: Teich, Andrew F., et al.
Publicado: (2016)

An Intracellular Threonine of Amyloid-β Precursor Protein Mediates Synaptic Plasticity Deficits and Memory Loss
por: Lombino, Franco, et al.
Publicado: (2013)

Synaptic and memory dysfunction induced by tau oligomers is rescued by up-regulation of the nitric oxide cascade
por: Acquarone, Erica, et al.
Publicado: (2019)

A role for cGMP-dependent protein kinase II in AMPA receptor trafficking and synaptic plasticity
por: Serulle, Yafelle, et al.
Publicado: (2009)

Commentary: Analysis of SUMO1-conjugation at synapses
por: Wilkinson, Kevin A., et al.
Publicado: (2017)

Development of Novel In Vivo Chemical Probes to Address CNS Protein Kinase Involvement in Synaptic Dysfunction
por: Watterson, D. Martin, et al.
Publicado: (2013)

Involvement of p38 MAPK in Synaptic Function and Dysfunction
por: Falcicchia, Chiara, et al.
Publicado: (2020)

β- but not γ-secretase proteolysis of APP causes synaptic and memory deficits in a mouse model of dementia
por: Tamayev, Robert, et al.
Publicado: (2012)

Notoginsenoside R1 increases neuronal excitability and ameliorates synaptic and memory dysfunction following amyloid elevation
por: Yan, Shijun, et al.
Publicado: (2014)

Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer’s models
por: Lourenco, Mychael V., et al.
Publicado: (2019)

Leucine Carboxyl Methyltransferase 1 Overexpression Protects Against Cognitive and Electrophysiological Impairments in Tg2576 APP Transgenic Mice
por: Gnanaprakash, Madhumathi, et al.
Publicado: (2021)

LTP and memory impairment caused by extracellular Aβ and Tau oligomers is APP-dependent
por: Puzzo, Daniela, et al.
Publicado: (2017)

Reactive Oxygen Species: Physiological and Physiopathological Effects on Synaptic Plasticity
por: Beckhauser, Thiago Fernando, et al.
Publicado: (2016)

Synaptic GluN2A-Containing NMDA Receptors: From Physiology to Pathological Synaptic Plasticity
por: Franchini, Luca, et al.
Publicado: (2020)

Synaptotagmin 7 switches short-term synaptic plasticity from depression to facilitation by suppressing synaptic transmission
por: Fujii, Takaaki, et al.
Publicado: (2021)

Proteomics datasets of developing rat brain: Synaptic proteome and SUMO2/3-ylome
por: Kieffer, Félicie, et al.
Publicado: (2022)

Modeling of Zinc Dynamics in the Synaptic Cleft: Implications for Cadherin Mediated Adhesion and Synaptic Plasticity
por: Wolf, Christoph, et al.
Publicado: (2018)

SUMO-modifying Huntington’s disease
por: Soares, Ericks S., et al.
Publicado: (2022)

All-optical physiology resolves a synaptic basis for behavioral timescale plasticity
por: Fan, Linlin Z., et al.
Publicado: (2023)

Identification of SUMO activating enzyme 1 inhibitors utilizing virtual screening approach
por: Kumar, Ashutosh, et al.
Publicado: (2014)

Total Chemical Synthesis of SUMO and SUMO‐Based Probes for Profiling the Activity of SUMO‐Specific Proteases
por: Mulder, Monique P. C., et al.
Publicado: (2018)

Caspases in synaptic plasticity
por: Li, Zheng, et al.
Publicado: (2012)

Imaging synaptic plasticity
por: Padamsey, Zahid, et al.
Publicado: (2011)

Microglial large extracellular vesicles propagate early synaptic dysfunction in Alzheimer’s disease
por: Gabrielli, Martina, et al.
Publicado: (2022)

Modulation of synaptic plasticity, motor unit physiology, and TDP-43 pathology by CHCHD10
por: Liu, Tian, et al.
Publicado: (2022)

Molecular physiology of Arc/Arg3.1: The oligomeric state hypothesis of synaptic plasticity
por: Eriksen, Maria Steene, et al.
Publicado: (2022)

Abolishing Tau cleavage by caspases at Aspartate(421) causes memory/synaptic plasticity deficits and pre-pathological Tau alterations
por: Biundo, F, et al.
Publicado: (2017)

Translational inhibition of APP by Posiphen: Efficacy, pharmacodynamics, and pharmacokinetics in the APP/PS1 mouse
por: Teich, Andrew F., et al.
Publicado: (2018)

Sumo-dependent substrate targeting of the SUMO protease Ulp1
por: Elmore, Zachary C, et al.
Publicado: (2011)

Identification of proximal SUMO-dependent interactors using SUMO-ID
por: Barroso-Gomila, Orhi, et al.
Publicado: (2021)

Targeting Human Central Nervous System Protein Kinases: An Isoform Selective p38αMAPK Inhibitor That Attenuates Disease Progression in Alzheimer’s Disease Mouse Models
por: Roy, Saktimayee M., et al.
Publicado: (2015)

Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers I: Abeta 42 Oligomer Binding to Specific Neuronal Receptors Is Displaced by Drug Candidates That Improve Cognitive Deficits
por: Izzo, Nicholas J., et al.
Publicado: (2014)

Competition for synaptic building blocks shapes synaptic plasticity
por: Triesch, Jochen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_scperl5t1g1hpjfbftfhnltem8